ES446075A1 - Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo. - Google Patents

Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo.

Info

Publication number
ES446075A1
ES446075A1 ES446075A ES446075A ES446075A1 ES 446075 A1 ES446075 A1 ES 446075A1 ES 446075 A ES446075 A ES 446075A ES 446075 A ES446075 A ES 446075A ES 446075 A1 ES446075 A1 ES 446075A1
Authority
ES
Spain
Prior art keywords
mixture
weight
gastric juice
sustained
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446075A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of ES446075A1 publication Critical patent/ES446075A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES446075A 1975-03-17 1976-03-16 Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo. Expired ES446075A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
ES446075A1 true ES446075A1 (es) 1977-09-16

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
ES446075A Expired ES446075A1 (es) 1975-03-17 1976-03-16 Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo.

Country Status (21)

Country Link
JP (1) JPS51115910A (de)
AR (1) AR222624A1 (de)
AT (1) AT353415B (de)
AU (1) AU505355B2 (de)
CA (1) CA1073358A (de)
CH (1) CH630257A5 (de)
DD (1) DD124102A5 (de)
DE (1) DE2611041A1 (de)
DK (1) DK148344C (de)
ES (1) ES446075A1 (de)
FR (1) FR2304354A1 (de)
GB (1) GB1546448A (de)
GR (1) GR60341B (de)
IE (1) IE43083B1 (de)
LU (1) LU74558A1 (de)
MC (1) MC1101A1 (de)
NL (1) NL190313C (de)
NZ (1) NZ180321A (de)
PH (1) PH14927A (de)
PT (1) PT64907B (de)
SE (1) SE433804B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
PL169106B1 (pl) * 1991-01-30 1996-06-28 Wellcome Found Sposób wytwarzania dyspergowalnej w wodzie tabletki PL PL PL PL PL PL PL
ATE170745T1 (de) * 1991-04-08 1998-09-15 Nippon Shinyaku Co Ltd Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt
ATE173159T1 (de) * 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
AU8000494A (en) * 1993-10-29 1995-05-22 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
CN1108150C (zh) * 1994-05-13 2003-05-14 史密丝克莱恩比彻姆公司 增加钙摄取的方法及所用的制剂
EP0793485A4 (de) * 1994-12-01 1998-08-26 Cibus Pharmaceutical Inc Arzmeimittelabgabesystem mit verzögerter freisetzung unter verwendung eines pulverförmigen hydrokolloidgummi aus höheren pflanzen
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (de) 2001-03-31 2002-10-02 Jagotec Ag Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (de) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
LU74558A1 (de) 1977-09-27
FR2304354B1 (de) 1979-04-27
GR60341B (en) 1978-05-17
PH14927A (en) 1982-01-29
IE43083B1 (en) 1980-12-17
SE7603325L (sv) 1976-09-18
PT64907A (fr) 1976-04-01
CH630257A5 (en) 1982-06-15
ATA192276A (de) 1979-04-15
SE433804B (sv) 1984-06-18
JPS638084B2 (de) 1988-02-19
PT64907B (fr) 1978-03-24
DD124102A5 (de) 1977-02-02
GB1546448A (en) 1979-05-23
NL7602776A (nl) 1976-09-21
NL190313C (nl) 1994-01-17
NL190313B (nl) 1993-08-16
DK148344C (da) 1985-11-04
JPS51115910A (en) 1976-10-13
DK148344B (da) 1985-06-17
DE2611041C2 (de) 1988-06-09
NZ180321A (en) 1978-06-20
AT353415B (de) 1979-11-12
CA1073358A (en) 1980-03-11
MC1101A1 (fr) 1977-02-04
FR2304354A1 (fr) 1976-10-15
DE2611041A1 (de) 1976-10-14
AU505355B2 (en) 1979-11-15
AR222624A1 (es) 1981-06-15
DK113676A (da) 1976-09-18
AU1204976A (en) 1977-09-22
IE43083L (en) 1976-09-17

Similar Documents

Publication Publication Date Title
ES446075A1 (es) Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo.
ES8500739A1 (es) Metodo de producir composiciones farmaceuticas de liberacion controlada y accion prolongada
ES8402155A1 (es) Un metodo para producir formas posologicas unitarias solidas que al administrarse siguen una pauta de liberacion regular y prolongada.
ES8104911A1 (es) Procedimiento para preparar una composicion terapeutica de liberacion retardada, conformada y comprimida, que contiene una sustancia terapeuticamente activa incorporada en un ma- terial excipiente de hidroxipropilmetilcelulosa
ES2000577A6 (es) Procedimiento para la preparacion de una forma granulada, de liberacion retardada de una sustancia farmaceuticamente activa
ES424533A1 (es) Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
ES8607009A1 (es) Un metodo para preparar una forma de dosificacion unitaria solida, terapeuticamente activa
EP0350701A3 (de) Arzneimittel zur oralen Verabreichung mit analgetischer und antiinflammatorischer Wirkung, die einen ausgezeichneten Geschmack besitzen und frei von irritierenden Effekten auf die Schleimhäute sind
AU528310B2 (en) Composition of paracetamol and metoclopramide
SE8001599L (sv) Transdermalt medicineringssystem for isosorbiddinitrat
EP0135171A3 (de) Pharmazeutische Zusammensetzung zur Anwendung von Interferon
GB2089210A (en) Polymeric diffusion matrix for administration of drugs
ES8400028A1 (es) Metodo de preparacion de una composicion tixotropica anhidra.
GB1504553A (en) Tablet formulations
GB8603964D0 (en) Compositions
JPS5218832A (en) Method of making cosmetic preparation
JPS5750914A (en) Betamethasone external pharmaceutical
ES8502332A1 (es) Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral
JPS56169623A (en) Anti-inflammatory and pain-killing spreading plaster
ES469840A1 (es) Procedimiento para la obtencion de nuevos derivados de tria-zolotiadiacinas.
JPS52130905A (en) Medicinal composition
SE7610968L (sv) Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat
IL61418A (en) Fluorine-substituted benzyl esters of 2,2,3,3-tetramethyl cyclopropane-1-carboxylic acid,their preparation and their use as pesticides
JPS53111395A (en) Preparation of nonfoamable urethane elastomer
JPS5626910A (en) Preparation of slow-release anticancer complex composition